Lactate dehydrogenase-1 (EC 1.1.1.27), intravenously injected into rabbits, was cleared with first-order kinetics (half-life 27 mm), until at least 80% of the injected activity had disappeared from plasma. Radioactivity from injected 1251.. labeled enzyme disappeared at this same rate. Trichloroacetic-acid-soluble breakdown products started to appear in the circulation shortly after injection of the labeled enzyme. Body scans of the rabbits for 80 mm after injection of 131 I-labeled enzyme revealed rapid accumulation of label in the liver, peaking 10-20 mm after injection. Subsequently, activity in the liver declined and radioactivity (probably labeled breakdown products of low molecular mass) steadily accumulated in the bladder. Tissue fractionation of liver, 19 mm after injection of labeled enzyme, indicated that the radioactivity was present both in endosomes and in lysosomes, suggesting uptake by endocytosis, followed by breakdown in the lysosomes. Measurements of radioactivity in liver and plasma suggest that the liver is responsible for the breakdown of at least 75% of the injected enzyme. Radioautography of tissue sections of liver and spleen showed accumulated radioactivity In sinusoidal liver cells and red pulpa, respectively. These results are very similar to those for lactate dehydrogenase-5, creatine kinase MM, and several other enzymes that we have previously studied in rats.
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Concentrations
of enzymes in plasma are often used to determine the extent and follow the course of tissue injuries (1). These concentrations depend not only on the rate at which the enzyme is released from the injured tissue, but also on its rate of elimination.
For ethical and practical reasons, plasma clearance and catabolism of injected enzymes can be studied only in experimental animals.
In previous work, we have provided evidence that the rapid plasma clearance in rats of lactate dehydrogenase (LD; EC 1.1.1.27) isoenzyme 5,3 cytosolic and mitochondrial isoenzymes of malate dehydrogenase, alcohol dehydrogenase, adenylate kinase, creatine kinase isoenzyme MM, and mitochondrial aspartate aminotransferase is mainly due to receptor-mediated endocytosis by macrophages from liver, spleen, and bone marrow (2) (3) (4) .
In rats, LD-1, the principal LD isoenzyme from heart, is cleared much more slowly than the enzynles mentioned above. For practical reasons, the fate of conventionally 'Department of Biochemistry, Groningen University, Nijenborgh 16, 9747 AG Groningen, The Netherlands.
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ReceivedAugust 15, 1988; acceptedSeptember 29, 1988. labeled enzymes that are cleared slowly cannot be studied accurately (see Discussion). However, clearance of LD-1 is relatively rapid in rabbits and the fate of 'I-labeled LD-1 in this species has been studied by Wilkinson and Qureshi (5) . They found a major, rapid initial phase of clearance from plasma, lasting about 3 h, followed by a minor, much slower clearance phase of about 30 h. The tissue distribution of the label was not determined until 6 h after the enzyme was injected. Results of these experiments led Wilkinson and Qureshi to conclude that the principal, initial clearance phase reflected the distribution of the injected enzyme throughout the extracellular fluid and that inactivation and breakdown of the enzyme in either the plasma, or in a compartment in close proximity to it, took place in the minor, second phase.
We have now repeated the experiments of Wilkinson and Qureshi, using, among other methods, body scanning to monitor continuously the fate of the radiolabel. Our results show that the main, initial clearance phase is not ascribable to distribution, but rather to endocytosis and subsequent breakdown of the enzyme in the liver and, to some extent, in other tissues.
Materials and Methods

Materials
LD-1 from porcine heart, LD-5 from porcine muscle, and alcohol dehydrogenase from horse liver [as suspensions in (NH4)2S04] were obtained from Boehringer Mannheim, Mannheim F.R.G. Pig-heart cytosolic malate dehydrogenase [as a suspension in (NH4)2S04} was obtained from Sigma Chemical Co., St. Louis, MO, and purified by us as described elsewhere (6). 5'-AMP-Sepharose 4B was obtained from Pharmacia, Uppsala, Sweden; "lodogen" from Pierce Chemical Co., Rockford, IL; and "Hypnorm" anesthetic (a solution containing 10 mg of fluanisone and 0.3 15 mg offentanyl citrate per milliliter) from Janssen Pharmaceutica, Goirle, The Netherlands. NaI and Na'31! (carrier-free) were from Amersham International,
Amersham,
U.K.
Procedures
Labeling ofW-i.
LD-1 was labeled with 'I and 131j in the same way as described for LD-5 (3). Briefly, the procedure is as follows. We incubated 5mg of enzyme in 50 mmoll L sodium borate buffer, pH 9.2, with 9.4 ninol of Na'I and 2 mCi of Na'I or Na'3I for 30 ruin at 0 #{176}C in a glass tube coated with 1 mg of lodogen. The labeled LD-1 was separated from free iodide and any labeled nonenzymatic material by affinity chromatography on 5'-AMP-Sepharose 4B as described by de Jong et al. (7) . The labeled enzyme was eluted from the column with a solution containing 0.2 mmol of NADH per liter and retained about 90% of its enzymatic activity. Less than 1% of label was soluble in trichioroacetic acid solution (200 g/L).
Body scintifraphy. For body scintigraphy of rabbits after injection of 1 'I-labeled protein we used a gamma camera equipped with a high-energy parallel-hole collimator. Uptake by organs was measured for 80 miii in analog pictures taken during various 5-ruin intervals. Simultaneously, digital frames of results for 2-mm periods were stored in the memory of a dedicated computer system, to use in evaluating the kinetics of the tracer in liver and bladder. With a standard region-of-interest technique, curves of these organ activities can be generated. During the scanning, the animals were kept under light anesthesia induced by intramuscular injection of 0.5-1.0 mL of Hypnorm per kilogram of body weight.
Radioautography.
To obtain radioautograms, we injected rabbits with 0.3 mg of highly labeled LD-1 preparations (100 Ci of 'I per milligram of protein), and prepared radioautograms as described previously (8).
Assay of radioactivity.
We determined the amount of radioactivity remaining in the plasma after precipitation of protein by mixing 20 pL of plasma with 0.1 mL of a carrier solution containing bovine serum albumin (100 gIL), followed by the addition of 0.1 mL of 220 g/L trichloroacetic acid solution. We measured radioactivity in the homogenates and the subcellular fractions by adding 0.5 mL of 200 g/L trichloroacetic acid reagent to 0.5 mL of the homogenate or fraction and counted the radioactivity of the supernates and the precipitates.
Handling of animals; fractionations of liver. New Zealand White rabbits of either sex, weighing between 1800 and 3500 g, were injected in the marginal vein of the left ear with phosphate-buffered isotonicsaline, 1.0 mL per kilogram of body weight, usually containing 0.3 mg of enzyme per milliliter. Solutions to be injected were centrifuged for 5 mm at 12000 x g immediately before injection to remove any insoluble material.
Blood sampled from the marginal ear vein of the right ear was centrifuged in heparinized tubes. Plasma volume was assumed to be 44 mL per kilogram body wt. (9). We measured LI) activity in a blood sample taken before injecting the labeled enzyme, so that we could correct the enzyme activities measured in plasma after injecting for endogenous activity. At 19 ruin after injection of labeled LD-1 we perfused livers in situ with icecold phosphate-buffered saline until they became yellowish. Spleen and kidneys were not perfused. Liver, spleen, and kidneys were excised and, after weighing them, we placed spleen, kidneys, and part of the liver in separate solutions of ice-cold 250 mmoIJL sucrose solution, homogenized them, and assayed each for radioactivity and protein. Bone marrow obtained from the femora was also suspended in the sucrose solution. Differential fractionations of liver and determination of reference enzymes were done as described by Bouma and Gruber (10).
Determination
of enzyme activity and protein content. To estimate enzyme concentrations, we measured the absorbance at 280 nm as described previously (3). For LD-1, an , value of 1.37 was used (11). The enzyme activities of U) and mitochondrial and cytosolic malate dehydrogenase (EC 1.1.1.37) were determined as described before ( 
Results
Clearance of LD-1 from Plasma
Intravenously injected LD-1 was cleared from plasma with first-order kinetics, showing a mean (n = 10) half-life of 27 (SD 6) ruin, until at least 80% of the injected dose had disappeared from the circulation. The y-axis intercept, determined by extrapolation, corresponded to 107% (SD 20%) of the dose. Immediately after injection, enzyme activity of plasma was increased by 20-to 100-fold as compared with values in untreated rabbits.
When 'I-labeled enzyme was used, enzyme activity and acid-precipitable (i.e., protein-bound) radioactivity were cleared monoexponentially at the same rate ( Figure IA) : plasma half-lives of enzyme activity and acid-precipitable radioactivity as calculated by means of the least-squares method were 32 (SD 6) and 36 (SD 7) miii, respectively. The intercept with the y-axis was 99% (SD 9%) for enzyme activity and 95% (SD 12%) for acid-precipitable radioactivity. Acid-soluble radioactivity (i.e., free iodide or label bound to amino acids or small peptides) started to appear in the circulation soon after injection. Its concentration reached a plateau -60 ruin after injection of the protein, corresponding to an amount in plasma of -6% of the injected dose The localization of label in the rabbit was continuously monitored with a gamma camera for 80 miii after intravenous injection of '311-labeled LD-1. The orientation of the rabbit during scanning is schematically shown in Figure  2A . The approximate position of the liver was previously made visible by injection of 9#{176}'Tc colloid, which is phagocytosed by the reticuloendothelial system. The distribution of radioactivity during 5-rein periods-viz., at 15-20, 30-35, and 60-65 rein after injection of the enzyme-is shown in Figure 2 , B-D. As Figure 2B shows, the label was strongly concentrated in the liver area 15-20 ruin after injection. In the next 45 min, a gradual redistribution of label was observed: the radioactivity of the liver decreased and the label became concentrated in the bladder area (Figure 2, C  andD) . Figure 3 shows radioactivity curves for the liver and the bladder during the whole scanning period. Label accumulated rapidly in the liver, reached a maximum -15 mm after injection, then started to decline. A different pattern was observed in the bladder, where label started to appear after a lag period of about 20 miii and continuously increased during the rest of the experiment. A similar pattern was observed in two other rabbits, with maxima for liver at 17 and 13 miii, respectively.
Quantitative Assessment of Uptake
Scanning makes it possible to follow the distribution of label to the tissues over time. The values obtained, however, can not be converted to amounts or percentages of injected label. To obtain such data, we did additional experiments. Rabbits were injected with 'I-labeled LD-1 and homogenates of excised tissues were counted in a scintillation counter 19 miii after injection. The results are summarized in Table 1 . Liver contained 24% (SD 3%) of the dose; 30% (SD 4%) of the label in liver was trichloroacetic acid-soluble. Only 0.6% (SD 0.2%) of the dose was found in the spleen. The concentration of label, expressed per gram of tissue protein, was highest in spleen and bone marrow.
Subcellular Localization of Label in Liver
Evidence for the involvement of lysosomes in the catabolism of the enzyme was obtained by differential fractionation of liver homogenates 19 ruin after injection of labeled LD-1 (Figure 4) . Most of the acid-precipitable radioactivity was present in the subcellular particles. The distribution pattern found is intermediate between that of the lysosomal EC 3.1.3.9) , suggesting the presence of the enzyme in lysosomes and small particles, probably endosomes. Trichloroacetic-acid-soluble activity was mainly present in the cytosol fraction.
These findings are compatible with the hypothesis that Thus, the area ofeach blodc is proportionalto the percentageof homogenate activityrecoveredin the fraction.Averageanalyticalrecoveriesfrom the homogenateswere:acidphoephatase, 98%; glucoee-6-phoaphatase, 108%; acid-precipmtableradioactivity, 87%; acId-soluble radioactivity, 143%; and protein, 94%
2478 CLINICALCHEMISTRY, Vol. 34, No. 12, 1988 LD-1 is taken up by endocytosis. After endocytosis the enzyme is transported by endosomes to lysosomes, where it is rapidly degraded. Trichloroacetic-acid-soluble breakdown products diffuse from the tissue to the blood. Endocytosis is known to be a rapid process. Low-density lipoprotein, for instance, is transported from the plasma membrane to the lysosome within 10 mm (14).
Identification of Cells involved in Uptake of LD-1
To determine the cell type involved in the catabolism of LD-1, tissue sections of liver and spleen were subjected to radioautography ( Figure 5 ). In liver, grains were predominantly present in clusters above sinusoidal cells. The distribution suggests localization in Kupffer cells, but involvement of endothelial cells cannot be excluded. Radioactivity in spleen was localized above the red pulpa. It is therefore likely that macrophages are endocytosing LD-1 in these tissues.
Clearance of Other Enzymes
LD-1 is cleared much more rapidly in the rabbit than in the rat. This does not hold for several other enzymes. Three other dehydrogenases, which are also removed with firstorder kinetics, were cleared with half-lives that were three to six times as long as those in the rat (Table 2 ).
Discussion
Our rabbit is caused by endocytosis of the enzyme by the liver and, to a lesser degree, also by spleen and bone marrow. After endocytosis, the protein is rapidly degraded in the lysosomes.Acid-soluble breakdown products appear in plasma and are subsequently mostly excreted in the urine.
Mthough our interpretation of the experiments differs
fundamentally from that of Wilkinson and Qureshi (5), who attributed the main clearance phase to distribution of the injected enzyme throughout the extracellular fluid, their results are compatible with our hypothesis. Wilkinson and Qureshi found that enzyme activity and radioactivity of 'Ilabeled LD-1 were cleared with a half-life of 31 mm until -95% had disappeared from plasma, in perfect agreement with our data. It is not possible to evaluate the significance of the tissue distribution of label, which they determined 6 h after injection of the enzyme, because it is not clear which percentage of the injected dose was left in the tissues. Moreover, it is clear from our data that most of the injected enzyme is already broken down 6 h after injection and that labeled breakdown products have disappeared from the catabolizing tissues. In agreement with this concept, Wilkinson and Qureshi found 60-70% of the dose in the urine collected up to 72 h after the injection. This is compatible with the accumulation of label in the area of the bladder that we see 1 h after injection ( Figure 2D) . Analysis of the radioactive products in urine by Wilkinson and Qureshi showed that these consisted of free iodide and iodinated amino acids, mainly tyrosine and histidine, which might well have been formed by intralysosomal breakdown of the radioiodinated enzyme (15) . 0Average values reported in references(2) and (8).
Rabbits
Our experiments differ from those of Qureshi and Wilkinson in that they used rabbit LD-1, whereas we did our experiments with the porcine enzyme. The virtually identical half-lives found in both studies suggest that the rabbit and porcine enzymes are treated in the same way. Although this might be a coincidence, our previous experiments on rats suggest that it is not. In these experiments, we found that porcine, rabbit, and rat LD-5 showed the same halflives after intravenous injection into rats (8). Moreover, extensive in vitro work showed that the affinity of porcine and rat LD-5 for the receptor that mediates their endocytosis by rat Kupifer cells was identical; the same was true for rat and rabbit creatine kinase MM (3).
The sharp radioactivity peak in liver (Figure 3) indicates that breakdown of LD-1 is rapid compared with its uptake; if, at the other extreme, the protein was not broken down at all, accumulation of label would go on for a few hours until the enzyme had virtually disappeared from the circulation. Proteins that are much more slowly endocytosed than LD-1, but also rapidly degraded, would not show any significant accumulation of label in liver and other tissues. This situation might prevail for many enzymes that are cleared slowly from plasma. As mentioned in the Introduction, this is the reason why we have studied the clearance of LD-1 in rabbits, where the enzyme is cleared rapidly.
Our findings for LD-1 in rabbits are very similar to those obtained with LD-5 and other enzymes in the rat (see ref. 4  for a review) . In rats we observed a half-life in plasma of 28 miii for LD-5 and a maximum of radioactivity in the liver about 13 mm after injection of labeled enzyme. At that time -15% of the dosewas found in the liver. The amount of label present in the liver declined thereafter, owing to leakage of labeled breakdown products from the tissue. If clearance from plasma is a first-order process and if the rate of uptake by the tissues is proportional to the concentration in plasma (8), one can calculate to what extent tissues such as liver and spleen are involved in the catabolism of the enzyme. We calculated that, in the rat, liver and spleen are responsible for the catabolism of 41% and 11% of the circulating LD-5, respectively (7). A similar calculation can be made for the catabolism of LD-1 in rabbits. Liver contains 24% (SD 3%) of the dose 19 mm after injection (Table 1) . Using a value of 24% and a plasma half-life of 27 mm, it can easily be calculated that the liver is responsible for the elimination from plasma of 62% of the circulating LD-1. As Figure 3 (and similar curves obtained from other rabbits) suggests, liver might contain at least the same percentage of the dose 10-15 nun after injection, when an even smaller amount of enzyme has been cleared from the circulation. Thus, it is Rats likely that uptake and catabolism by liver accounts for at The in vitro experiments with rat Kupifer cells indicated that LD-1 has a low, but significant, affinity for this receptor (3). A similar situation might exist in other species where LD-1 is cleared much more slowly than LD-5 (Table 3 ). It is likely that a similar receptor, responsible for the clearance of cytosolic malate dehydrogenase, alcohol dehydrogenase, and LD-5 (Table 2 ) also exists in rabbits. The rabbit receptor might just be exceptional in that it binds LD-1 with higher affinity than the receptor in other species.
As Table 3 shows, the half-life of LD-1 is about two orders of magnitude longer in man than in the rabbit, and the halflife of LD-5 in man is at least 10-fold that found in the rat. These very big differences cannot be explained by dissimilarities in the ratio between blood volume and liver weight, and the hepatic blood flow per gram of liver. Possible explanations are that (a) fewer of the putative receptors that mediate endocytosis of enzymes by macrophages in the rabbit and the rat are present on human cells and (or) that (b) the human receptors have lower affinities for the enzymes.
The conventionally accepted average half4ife for LD-1 (110 h) in humans as determined by Bar and Ohlendorf(24) was recently confirmed by Smith et al. (25) , who used radioimmunoassay in addition to enzyme determinations. The half-lives calculated by these authors were determined in patients suffering from myocardial infarction or other (25) organ injuries. According to Hermens and Willems (23) , it is likely that these data overestimate the real values, owing to the continuing release of enzymes from the injured tissues and resupply of activity from the extravascular pool. Recently, these authors devised a method to correct for these events. In this way, significantly shorter half4ives (50 h for LD-1 and 6 h for LD-5) were obtained. Release of enzymes might continue longer in one patient than in another, and such interindividual variation might contribute to the great variability in apparent half-lives observed by Smith et al. (25) .
The concept that LD-isoenzymes are eliminated from plasma by endocytosing liver cells does not stand on its own. Husic and Suelter (26, 27) have provided evidence that in chickens AMP aminohydrolase (EC 3.5.4.6) is cleared from plasma via endocytosis by parenchymal liver cells, by a mechanism that can be inhibited by sulfated polysaccharides. Other studies have shown that glycoproteins with 
